Area of research
Oncology · Otorhinolaryngology
Research interest
Research interests include Medicine, Clinical endpoint, Hazard ratio, Melanoma, Internal medicine, and Denosumab.
Mobilise-D insights to estimate real-world walking speed in multiple conditions with a wearable device
Neoadjuvant talimogene laherparepvec plus surgery versus surgery alone for resectable stage IIIB–IVM1a melanoma: a randomized, open-label, phase 2 trial
Talimogene Laherparepvec and Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY-232): A Multicenter, Phase 1b Study
Femoral and Vertebral Strength Improvements in Postmenopausal Women With Osteoporosis Treated With Denosumab